L. Mollanazar

Biography

Leandra Mollanazar joined SCI in December 2016 as Senior Vice President and General Manager.  Ms. Mollanazar has more than twenty-five years in the pharmaceutical and medical device industries in various executive leadership and global quality operation roles.  Ms. Mollanazar has broad and extensive expertise in varying pharmaceutical and medical technologies and industry standards including sterilization methods, finished product packaging configurations and supply chain tools as well as management of Research and Development, Clinical Trials and Commercial arenas. In addition, Ms. Mollanazar has extensive Global Regulatory Compliance experience with US, EU and other regulatory authorities throughout the world. Prior to joining SCI, Ms. Mollanazar was with Catalent Pharma Solutions for more than thirteen years with her most recent role as Vice President of Quality Operations for Softgel technologies spanning eleven global manufacturing sites in the US, EU, Latin America and Asia Pacific.  Catalent is a global leader in development solutions and advanced drug delivery technologies, including softgels, for drugs, biologics, and consumer health care products.  Prior to joining Catalent, Ms. Mollanazar’s career crossed varying leadership operational and quality roles at Bausch & Lomb in aseptic manufacturing, analytical testing, packaging and distribution of ophthalmic, otic, inhalation and topical drug products. She also spent time at Johnson and Johnson where they manufactured vascular access and patient monitoring medical devices for global markets.  

Research Interest

Chemistry